Embecta (EMBC) EBT Margin (2020 - 2026)

Embecta (EMBC) posted EBT Margin of 4.28% for Q1 2026, down 81.01% sequentially from 22.55% in Q4 2025, and down 954.0% YoY from 0.5% in Q1 2025.

Embecta (EMBC) EBT Margin (2020 - 2026) Analysis & Trends

Embecta has reported EBT Margin for 7 years, with the latest figure at 4.28% in Q1 2026.

Quarterly EBT Margin fell 954.0% year-over-year to 4.28% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 16.27% (up 1116.0% YoY) and the FY2025 annual result came in at 12.62%, up 868.0% from the prior year.
EBT Margin eased to 4.28% in Q1 2026 per EMBC's latest filing, from 22.55% in the prior quarter.
Over five years, EBT Margin peaked at 34.21% in Q1 2022 and troughed at 10.01% in Q3 2022.
A 5-year average of 10.55% and a median of 8.84% in 2023 frame the typical range for EBT Margin.
The sharpest annual moves came in 2022 and 2025: EBT Margin slumped 4871 bps in 2022, then surged 2282 bps in 2025.
Over 5 years, EBT Margin stood at 20.35% in 2022, then sank by 75 bps to 5.16% in 2023, then slumped by 105 bps to 0.27% in 2024, then soared by 8537 bps to 22.55% in 2025, then slumped by 81 bps to 4.28% in 2026.
According to Business Quant data, EBT Margin over the past three periods registered 4.28%, 22.55%, and 10.98% for Q1 2026, Q4 2025, and Q3 2025 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	EBT Margin (Qtr)
1	Intuitive Surgical	132.71 Bn	127.50 Bn	1.96 Bn	36.46%
2	Becton Dickinson	51.57 Bn	50.71 Bn	2.32 Bn	11.12%
3	Alcon	35.52 Bn	34.17 Bn	1.68 Bn	-1.63%
4	Resmed	33.28 Bn	31.81 Bn	861.22 Mn	32.40%
5	Medline	27.86 Bn	25.18 Bn	2.22 Bn	3.06%
6	West Pharmaceutical Services	25.15 Bn	24.71 Bn	329.20 Mn	20.65%
7	Solventum	15.31 Bn	14.91 Bn	1.29 Bn	4.89%
8	Cooper Companies	14.86 Bn	14.72 Bn	735.40 Mn	-4.48%
9	Baxter International	13.63 Bn	11.48 Bn	1.03 Bn	5.34%
10	Embecta	319.59 Mn	101.39 Mn	153.30 Mn	10.16%

Download Data